You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

NUTRACORT Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Nutracort patents expire, and what generic alternatives are available?

Nutracort is a drug marketed by Bausch, Healthpoint, and Dow Pharm. and is included in four NDAs.

The generic ingredient in NUTRACORT is hydrocortisone. There are sixty-seven drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the hydrocortisone profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Nutracort

A generic version of NUTRACORT was approved as hydrocortisone by IMPAX LABS INC on March 30th, 2007.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for NUTRACORT?
  • What are the global sales for NUTRACORT?
  • What is Average Wholesale Price for NUTRACORT?
Summary for NUTRACORT
Drug patent expirations by year for NUTRACORT
Recent Clinical Trials for NUTRACORT

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Children's Oncology GroupPhase 1
National Cancer Institute (NCI)Phase 1
EsPhALL network I-BFM Study GroupPhase 3

See all NUTRACORT clinical trials

US Patents and Regulatory Information for NUTRACORT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch NUTRACORT hydrocortisone CREAM;TOPICAL 080442-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Dow Pharm NUTRACORT hydrocortisone LOTION;TOPICAL 080443-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Bausch NUTRACORT hydrocortisone CREAM;TOPICAL 080442-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Healthpoint NUTRACORT hydrocortisone GEL;TOPICAL 084698-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Dow Pharm NUTRACORT hydrocortisone LOTION;TOPICAL 087644-001 Aug 24, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

EU/EMA Drug Approvals for NUTRACORT

Company Drugname Inn Product Number / Indication Status Generic Biosimilar Orphan Marketing Authorisation Marketing Refusal
Takeda Pharmaceuticals International AG Ireland Branch Plenadren hydrocortisone EMEA/H/C/002185
Treatment of adrenal insufficiency in adults.
Authorised no no no 2011-11-03
Diurnal Europe B.V. Alkindi hydrocortisone EMEA/H/C/004416
Replacement therapy of adrenal insufficiency in infants, children and adolescents (from birth to < 18 years old).
Authorised no no no 2018-02-09
Diurnal Europe B.V. Efmody hydrocortisone EMEA/H/C/005105
Treatment of congenital adrenal hyperplasia (CAH) in adolescents aged 12 years and over and adults.
Authorised no no no 2021-05-27
>Company >Drugname >Inn >Product Number / Indication >Status >Generic >Biosimilar >Orphan >Marketing Authorisation >Marketing Refusal

NUTRACORT Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Nutraceuticals: A Case Study on the North American Market

Introduction to Nutraceuticals

Nutraceuticals are products derived from food sources with extra health benefits in addition to the basic nutritional value found in foods. These products can include functional foods, functional beverages, and dietary supplements.

Market Size and Growth

The North American nutraceuticals market is experiencing significant growth, driven by several key factors. The market is projected to register a CAGR of 6.4% during the forecast period from 2024 to 2029[1].

Drivers of Market Growth

Increasing Demand for Preventive Healthcare

Consumers, particularly millennials, are increasingly interested in optimizing their current health and preventing future health issues. This has led to a surge in demand for fortified food and beverage products, which are rich in nutraceuticals[1].

Personalized Nutrition

The trend of personalized nutrition is on the rise, especially among individuals with specific health conditions such as gut-related issues. This personalized approach to nutrition is further stimulating market growth[1].

Aging Population

The aging population in North America is driving demand for functional foods and beverages that help prevent or mitigate age-related health conditions. This demographic shift is a significant driver of the nutraceutical market[1].

Increasing Healthcare Spending

Rising healthcare spending and increasing consumer disposable income are also propelling the growth of the nutraceutical market. Consumers are more willing to invest in products that offer proven health benefits[1].

Key Market Segments

Product Segmentation

The nutraceutical market is segmented into functional foods, functional beverages, and dietary supplements. Each segment is experiencing growth due to the diverse health benefits they offer, such as managing obesity, cardiovascular disease, and other health issues[4].

Geographic Segmentation

The United States holds the largest market share in the North American region due to high consumer interest in preventive healthcare and self-medication. Other regions, including Canada and Mexico, also contribute to the market growth but to a lesser extent[1].

Competitive Landscape

The North American nutraceutical market is highly competitive, with several major players such as PepsiCo Inc., General Mills Inc., Nestle SA, The Kellogg Company, and Herbalife International of America Inc. These companies are adopting strategies like product innovation, expansion, partnerships, and advanced distribution networks to maintain their market share[1].

Financial Trajectory

Revenue Projections

The nutraceutical market is expected to see substantial revenue growth. For instance, the global nutraceutical market was projected to grow by USD 149.89 billion during the period from 2019 to 2023, with a CAGR of 8%[4].

Market Concentration

The market concentration is high, indicating a competitive landscape where major players dominate the market. However, there is still room for innovation and new entrants, particularly those focusing on niche markets or personalized nutrition[1].

Challenges and Opportunities

High Cost of Nutraceuticals

One of the significant challenges facing the nutraceutical market is the high cost of these products. This can be a barrier to entry for many consumers, especially in lower-income demographics[4].

Regulatory Landscape

The regulatory environment plays a crucial role in the nutraceutical market. Companies must comply with stringent regulations to ensure the safety and efficacy of their products. This can be both a challenge and an opportunity, as compliance can enhance consumer trust and market credibility[3].

Technological Innovations

Technological advancements in food formulations and delivery systems are driving innovation in the nutraceutical market. For example, the use of antioxidants, probiotics, and polyunsaturated fatty acids in nutraceutical products is becoming more prevalent due to their proven health benefits[1].

Consumer Trends

Self-Administration and Non-Invasive Treatments

Similar to the topical drug delivery market, there is a growing preference for self-administration and non-invasive treatment methods in the nutraceutical sector. Consumers are increasingly opting for products that are easy to use and have minimal side effects[3].

Women's Health

The sales of women's nutraceutical products account for a significant share of the demographic sector. Health practitioners often recommend these products, contributing to their increased adoption among women[1].

Regional Analysis

United States

The United States is the largest market for nutraceuticals in North America, driven by consumer interest in preventive healthcare and the increasing demand for functional foods and beverages[1].

Other Regions

While the U.S. dominates the market, other regions such as Canada and Mexico are also experiencing growth, albeit at a slower pace. These markets offer opportunities for expansion and innovation.

Future Outlook

Market Projections

The nutraceutical market is expected to continue growing, driven by technological innovations, changing consumer preferences, and the increasing demand for health and wellness products. By 2029, the market is projected to reach significant revenue milestones, with a CAGR of 6.4%[1].

Potential Challenges

Despite the positive outlook, the market faces challenges such as regulatory hurdles, high product costs, and the need for continuous innovation to meet evolving consumer demands.

Key Takeaways

  • The North American nutraceutical market is growing at a CAGR of 6.4% from 2024 to 2029.
  • Key drivers include increasing demand for preventive healthcare, personalized nutrition, and an aging population.
  • The market is highly competitive with major players like PepsiCo Inc. and Nestle SA.
  • Technological innovations and changing consumer preferences are driving market growth.
  • Regulatory compliance and high product costs are significant challenges.

FAQs

What is the projected CAGR for the North American nutraceutical market from 2024 to 2029?

The North American nutraceutical market is projected to register a CAGR of 6.4% during the forecast period from 2024 to 2029[1].

Who are the major players in the North American nutraceutical market?

Major players include PepsiCo Inc., General Mills Inc., Nestle SA, The Kellogg Company, and Herbalife International of America Inc.[1].

What are the key segments of the nutraceutical market?

The market is segmented into functional foods, functional beverages, and dietary supplements[4].

What are the main drivers of the nutraceutical market?

Key drivers include increasing demand for preventive healthcare, personalized nutrition, and an aging population[1].

How does the regulatory landscape impact the nutraceutical market?

The regulatory environment is crucial, as companies must comply with stringent regulations to ensure product safety and efficacy, which can enhance consumer trust and market credibility[3].

Sources

  1. North America Nutraceutical Industry - Companies & Revenue. Mordor Intelligence.
  2. Supplementary Material for 'Estimation of Clinical Trial Success .... Academic.oup.com.
  3. Topical Drug Delivery Market is expected to generate a revenue of USD 177.97 Billion by 2031 Globally at 6.3% CAGR. GlobeNewswire.
  4. Nutraceuticals Market 2019-2023 | Technavio. Business Wire.
  5. FINAL REPORT Evaluation of Healthcare Costs and Utilization .... Interact for Health.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.